GalNAc Conjugate Hepatocyte Targeting: A Precision Approach in Therapeutic Delivery

What is GalNAc Conjugate Hepatocyte Targeting

GalNAc-conjugate hepatocyte targeting involves the attachment of siRNAs (small interfering ribonucleic acids) to galactosyl-N-acetylgalactosamine (GalNAc), a sugar molecule. This conjugation enables specific delivery of therapeutic siRNAs to liver cells, optimizing efficacy and reducing off-target effects.

The GalNAc moiety acts as a ligand that binds to the asialoglycoprotein receptor (ASGPR) on hepatocytes, facilitating targeted uptake by these cells.

Mechanism of Action

When siRNAs are conjugated with GalNAc, they can be administered systemically. The GalNAc moiety binds to the ASGPR on hepatocytes, which are highly abundant in the liver and have a high affinity for this ligand. This binding triggers endocytosis of the complex into the cell.

Once inside the hepatocyte, the siRNA is released from the GalNAc moiety and can then exert its therapeutic effects by silencing specific genes.

Importance in Therapeutic Applications

GalNAc-conjugated siRNAs have revolutionized RNAi-based therapies, particularly for liver diseases. By targeting hepatocytes specifically, these conjugates can achieve high therapeutic efficacy while minimizing side effects associated with off-target effects.

This approach has been successfully applied in the treatment of various liver conditions, including viral hepatitis and genetic disorders.

Real-World Examples

One notable example is patisiran (Onpattro), a GalNAc-conjugated siRNA approved for the treatment of hereditary transthyretin-mediated amyloidosis. Patisiran specifically targets liver cells, where it silences the gene responsible for producing abnormal TTR protein.

Another application is givosiran (Givlaari) for the treatment of acute hepatic porphyria, which also uses GalNAc-conjugated siRNA to target and silence specific genes in hepatocytes.

Frequently asked questions

Try it live

Everything above runs in your browser — open GalNAc Conjugate Hepatocyte Targeting and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.